Multifunctional Bioactive Nanozyme Systems for Enhanced Diabetic Wound Healing
Advanced Healthcare Materials · 2025-03 · 14 (8)
DOI: 10.1002/adhm.202401580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 30.07.2024. Verfasst von Suyue Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burns, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, 510080, China. Hauptthemen laut MEDLINE: Wound Healing, Nanoparticles, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Wundversorgung
Abstract (Originalsprache)
The protracted transition from inflammation to proliferation in diabetic wound healing poses significant challenges, exacerbated by persistent inflammatory responses and inadequate vascularization. To address these issues, a novel nanozymatic therapeutic approach utilizing asymmetrically structured MnO₂–Au–mSiO₂@aFGF Janus nanoparticles is engineered. Nanozymes featuring a mSiO₂ head and MnO₂ extensions, into which acidic fibroblast growth factor (aFGF) is encapsulated, resulting in MnO₂–Au–mSiO₂@aFGF Janus nanoparticles (mSAM@aFGF), are synthesized. This nanozyme system effectively emulates enzymatic activities of catalase (CAT) and superoxide dismutase (SOD), catalyzing degradation of reactive oxygen species (ROS) and generating oxygen. In addition, controlled release of aFGF fosters tissue regeneration and vascularization. In vitro studies demonstrate that mSAM@aFGF significantly alleviates oxidative stress in cells, and enhances cell proliferation, migration, and angiogenesis. An injectable hydrogel based on photocrosslinked hyaluronic acid (HAMA), incorporating the nanozymatic ROS‐scavenging and growth factor‐releasing system, is developed. The HAMA‐mSAM@aFGF hydrogel exhibits multifaceted benefits in a diabetic wound model, including injectability, wound adhesion, hemostasis, anti‐inflammatory effects, macrophage polarization from M1 to M2 phenotype, and promotion of vascularization. These attributes underscore the potential of this system to facilitate transition from chronic inflammation to the proliferative phase of wound repair, offering a promising therapeutic strategy for diabetic wound management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Burns, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, 510080, China.
- Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510080, China.
- Academy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin, 300072, China.
- Department of Burn and Plastic Surgery, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, Guangdong, 510180, China.
ORCID-Profile: Xiaoyuan Ji
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Gao, S., He, X., Liu, H., Liu, Y., Wang, H., Zhou, Z., Chen, L., Ji, X., Yang, R., & Xie, J. (2025). Multifunctional Bioactive Nanozyme Systems for Enhanced Diabetic Wound Healing. Advanced Healthcare Materials, 14(8). https://doi.org/10.1002/adhm.202401580
Vancouver
Gao S, He X, Liu H, Liu Y, Wang H, Zhou Z, et al. Multifunctional Bioactive Nanozyme Systems for Enhanced Diabetic Wound Healing. Advanced Healthcare Materials. 2025;14(8). doi:10.1002/adhm.202401580
BibTeX
@article{Gao2025,
author = {Gao, Suyue and He, Xuefeng and Liu, Hengdeng and Liu, Yiling and Wang, Hanwen and Zhou, Ziheng and Chen, Lei and Ji, Xiaoyuan and Yang, Ronghua and Xie, Julin},
title = {Multifunctional Bioactive Nanozyme Systems for Enhanced Diabetic Wound Healing},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {8},
doi = {10.1002/adhm.202401580}
}
EUVIMED